Skip to main content

Table 1 Patient demographics [Mean ± SD]

From: The influence of a long-term growth hormone treatment on lipid and glucose metabolism: a randomized trial in short Japanese children born small for gestational age

 

No treatment

0.033 mg/kg/day

0.067 mg/kg/day

 

n

 

n

 

n

Gender

 

15

 

31

 

34

 Male, %

46.7

7

64.5

20

58.8

20

 Female, %

53.3

8

35.5

11

41.2

14

Chronological age, years

5.32 ± 1.38

15

5.34 ± 1.46

31

5.27 ± 1.15

34

Height, cm

94.6 ± 8.6

15

95.9 ± 8.4

31

94.9 ± 7.3

34

Height SDS

-2.92 ± 0.53

15

-2.95 ± 0.64

31

-2.90 ± 0.67

34

BMI

14.07 ± 1.40

15

14.42 ± 1.26

31

14.16 ± 1.24

34

IGF-I, ng/mL

115.39 ± 51.01

15

117.25 ± 49.13

31

118.20 ± 49.10

34

IGF-I SDS

-1.03 ± 1.50

15

-0.75 ± 1.06

31

-0.63 ± 1.21

34

Insulin, μU/mL

2.6 ± 1.7

10

3.6 ± 2.1

26

3.2 ± 1.9

28

Glucose, mg/dL

79.8 ± 6.3

15

82.4 ± 10.4

31

78.2 ± 11.5

34

HbA1c (NGSP), %

5.08 ± 0.32

15

5.10 ± 0.29

31

5.00 ± 0.19

34

TC, mg/dL

173.5 ± 24.2

15

166.9 ± 29.8

31

181.4 ± 24.2

34

LDL-C, mg/dL

96.7 ± 18.9

15

94.8 ± 26.2

31

104.7 ± 25.0

34

HDL-C, mg/dL

60.4 ± 15.9

15

56.9 ± 9.6

31

61.9 ± 12.0

34

  1. SD standard deviation, SDS standard deviation score, BMI body mass index, IGF-I insulin-like growth factor-1, HbA 1c glycated hemoglobin A1c, NGSP National Glycohemoglobin Standardization Program, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol